PCG COMMITTEES
PCG DISEASE SITE COMMITTEE
Our PCG Disease Site Committee is highly experienced in the development, research, assessment, and implementation of proton therapy clinical trials for those affected by various forms of cancers.
Michael Chuong, MD
Disease Site Committee Chair
Miami Cancer Institute
J. Isabelle Choi, MD
Disease Site Committee Sub-Chair
Breast
New York Proton Center
Mark Mishra, MD
ManagerDisease Site Committee Sub-Chair Central Nervous System
Maryland Proton Center
Rupesh Kotecha, MD
Disease Site Committee Sub-Chair
Central Nervous System
Miami Cancer Institute
R. Charles Nichols, MD
Disease Site Committee Sub-Chair Gastrointestinal
University of Florida Proton Therapy Institute
Carlos Vargas, MD
Disease Site Committee Sub-Chair
Genitourinary
Mayo Clinic-Arizona
Michael Rutenberg, PhD, MD
Disease Site Committee Sub-Chair
Reirradiation
University of Florida Proton Therapy Institute
John Chang, MD
Disease Site Committee Sub-Chair
Head & Neck
Oklahoma Proton Center
Charles Simone, MD
Disease Site Committee Sub-Chair
Lung
New York Proton Center
Yolanda Tseng, MD
Disease Site Committee Sub-Chair
Lymphoma
Seattle Cancer Care Alliance Proton Therapy Center
Ronny Rotondo, MD
Disease Site Committee Sub-Chair
Pediatrics
University of Florida Proton Therapy Institute
Jonathan Ashman, MD
Disease Site Committee Sub-Chair
Mayo Clinic, Arizona
PCG PUBLICATIONS COMMITTEE
Our PCG Publications Committee is responsible for the evaluation of editorial research and material as well as the publication of various innovative studies.
John Chang, MD
Vice President/Treasurer
The California Protons Therapy Cancer Treatment Center
Lia M. Halasz, MD
Publications Committee
University of Washington, SCCA Proton Center
Brad Hoppe, MD, MPH
Publications Committee
Mayo Clinic Jacksonville
Carl Rossi, Jr, MD
Publications Committee
California Protons Cancer Therapy Center
Leslie T. Yonemoto, MD
Publications Committee
PCG Data Safety Monitoring Board
Our PCG Data Safety Monitoring Board manages the regulation and administration of clinical trial protocols and policies, to ensure patient safety.
Torunn Yock, MD
Data Safety Monitoring Board Chair
Massachusetts General Hospital
Richard Amos, PhD, Medical Physicist, MD
Anderson
Danielle Coschigano
Mayo Clinic, AZ
Mark Pankuch, PhD, Director of Medical Physics
Northwestern Medicine Chicago Proton Center
R Charles Nichols, MD
University of Florida Proton Therapy Institute
Randy Henderson, MD
University of Florida Proton Therapy Institute
Carlos Vargas, MD
Mayo Clinic, AZ
Charles Simone, MD
New York Proton Center
Sameer Keole, MD
Mayo Clinic, AZ
Chris Morris, MS
University of Florida Proton Therapy Institute
William Hartsell, MD Northwestern Medicine Proton Center
Hsi Wen Chien, PhD, Medical Physicist
Procure Oklahoma City
Stella Flampouri, PhD, Medical Physicist
University of Florida Proton Therapy Institute
Brandi Nyberg
Northwestern Medicine Chicago Proton Center
Andrew Chang, MD
California Protons Cancer Center
Mark Mishra, MD
University of Maryland School of Medicine
Abigail Berman, MD
Penn Center for Precision Medicine
Astellas Pharma US
Megan Prior
University of Florida Proton Therapy Institute
Rachel Strauss
Massachusetts General Hospital
WANT TO LEARN MORE?
Contact Proton Collaborative Group (PCG) today and a member of our highly trained staff will reach out to discuss any questions you may have.